Viridian Therapeutic (VRDN) PT Lowered to $20 at Wells Fargo
Tweet
Share
E-mailGet Alerts VRDN Hot Sheet
Price: $19.40 +4.98%
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
16 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Wells Fargo analyst Derek Archila lowered the price target on Viridian Therapeutic (NASDAQ: VRDN) to $20.00 (from $29.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Viridian Therapeutic (VRDN) PT Raised to $35 at RBC Capital
- Kardex AG (KARN:SW) PT Raised to CHF348 at UBS
- Persistent Systems Ltd. (PSYS:IN) PT Lowered to INR5,540 at BNP Paribas Exane
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
